Skip to content

EXCELSUS

Absorbed by SOPHARMA on 30-06-2025 KBO/BCE: BE 0886.339.775

Lifetime

18 annual accounts with figures on one time axis
peak of €537,211 in 2009
-€33,854▼ €17,674
lowest -€151,544 in 2022
€1.7m▼ 7.7%
peak of €92.1m in 2024
€92.1m▲ 1.4%
€2.4m▲ 13.8%
peak of 0 FTE in 2023
0 FTE 
Board4 names since 2012
4 directors and 3 others
Documentsfilings and deeds
02-06-202559 days before the deadline
2024abbreviated format
Gross margin from -€16,180 to -€33,854Dividend €450,000Cash from €944,554 to €2.1m

Key points

from the 2024 annual accounts, the last ones filed

Equity

€92.1m ▲ 1.4%
90.92023+1.7Profit-0.5Dividend92.12024

EXCELSUS paid out €450,000 in dividends. That is 26% of the 2024 profit.

Liquidity

36.90 was 58.54 in 2023

Short-term debts rose from €378,116 to €641,909.

Filings

18 annual accounts since 2007
AprilJune31 JulyOctober201020152020

The last five annual accounts were filed 24 to 123 days before the end of the period.

Turnover not published in the abbreviated or micro format

Board and ownership

Managing director
Managing director
Director, since 11-05-2024
Director, since 11-05-2024

Shares in 1 company,

Board & ownership

Recent changes

Merger: absorbed by SOPHARMA holds 630 shares · General meeting of 30-06-2025 · Gazette deed
Merger proposal: to be absorbed by SOPHARMA acts as permanent representative · holds 630 shares (100%) · holds 100% of the shares · Gazette deed
resigns as director Discharge granted to · General meeting of 26-12-2024 · Gazette deed
3 directors appointed (managing director), (managing director) and · Gazette deed
All 42 events

Official details

Source: KBO
Status
Absorbed by SOPHARMAmerger by absorption, June 2025
Activity
“Het uitvoeren van managementopdrachten, het verstrekken van adviezen inzake financiële, technische, commerciële en administratieve…” (deed in Dutch)From the articles, 9 activitiesNo NACE code in the KBO
Financial year end
31 December
Peppol
Not found in the Peppol Directory
Company details

Annual accounts 2024

€94.6m▲ 1.7%
Filing
Filed on 02-06-2025
Financials

Insights on EXCELSUS

Absorbed by SOPHARMA in June 2025. The last annual accounts are for financial year 2024.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about EXCELSUS

What is the company number of EXCELSUS?
The company number of EXCELSUS is 0886.339.775. The VAT number is the same number with BE in front: BE 0886.339.775.
What is the legal form of EXCELSUS?
The KBO register gives EXCELSUS the legal form “NV”.
Is EXCELSUS still active?
No. Absorbed in a merger on 30-06-2025.Company details
What is the turnover of EXCELSUS?
The annual accounts for financial year 2024 state no turnover. The abbreviated or micro format does not require it.Financials
Is EXCELSUS profitable?
In financial year 2024, EXCELSUS made a profit of €1.7m.
Where can I find the annual accounts of EXCELSUS?
EXCELSUS filed 18 annual accounts with the National Bank of Belgium, the latest for financial year 2024.

Next steps

Keep this company with today's facts in a case file.